ID
31601
Beschrijving
A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00808418
Link
https://clinicaltrials.gov/show/NCT00808418
Trefwoorden
Versies (1)
- 11-09-18 11-09-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
11 september 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Prostate Cancer NCT00808418
Eligibility Prostate Cancer NCT00808418
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Cardiovascular Disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0007222
Beschrijving
Metastatic malignant neoplasm to brain
Datatype
boolean
Alias
- UMLS CUI [1]
- C0220650
Beschrijving
Therapeutic procedure Cancer Other
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C1707251
Beschrijving
Condition Uncontrolled Clinical Significance
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0348080
- UMLS CUI [1,2]
- C0205318
- UMLS CUI [1,3]
- C2826293
Similar models
Eligibility Prostate Cancer NCT00808418
- StudyEvent: Eligibility
C1265611 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C1516728 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0392877 (UMLS CUI [2,2])
C0332183 (UMLS CUI [2,3])
C1707251 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])